Markets:

Overview

News

Currencies

International

Treasuries

Artivion, Inc. Common Stock (NY:AORT)

25.48 +0.35 (+1.39%)

Streaming Delayed Price Updated: 11:18 AM EDT, Sep 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Artivion, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >

Artivion (AORT) Stock Is Up, What You Need To Know

August 06, 2025

Shares of medical device company Artivion (NYSE:AORT) jumped 3% in the morning session after investment firm Stifel raised its price target on the stock to $36 from $30, while maintaining a Buy rating....

Via StockStory

Topics ETFs Stocks World Trade

What To Expect From Artivion’s (AORT) Q2 Earnings

August 05, 2025

Medical device company Artivion (NYSE:AORT) will be announcing earnings results this Thursday afternoon. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence Economy World Trade

1 Russell 2000 Stock for Long-Term Investors and 2 We Question

August 04, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

Earnings Scheduled For May 5, 2025 ↗

May 05, 2025

Via Benzinga

Breaking Down Artivion: 4 Analysts Share Their Views ↗

February 25, 2025

Via Benzinga

3 Healthcare Stocks with Warning Signs

July 23, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six...

Via StockStory

Topics Stocks

3 Profitable Stocks with Warning Signs

July 21, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know

July 11, 2025

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned...

Via StockStory

Topics ETFs Stocks World Trade

3 Small-Cap Stocks Skating on Thin Ice

June 25, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

June 17, 2025

Via Benzinga

Q1 Earnings Highs And Lows: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

May 28, 2025

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including...

Via StockStory

AORT Q1 Earnings Call: Early Product Launches and Supply Recovery Drive Outperformance

May 19, 2025

Medical device company Artivion (NYSE:AORT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 1.6% year on year to $98.98 million. The company’s full-year revenue...

Via StockStory

Topics Economy

3 High-Flying Stocks with Questionable Fundamentals

May 13, 2025

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...

Via StockStory

1 Healthcare Stock with Exciting Potential and 2 to Avoid

May 12, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Stocks

What Analysts Are Saying About Artivion Stock ↗

May 06, 2025

Via Benzinga

Artivion’s (NYSE:AORT) Q1: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations

May 05, 2025

Via StockStory

Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect

May 04, 2025

Medical device company Artivion (NYSE:AORT) will be reporting earnings tomorrow after the bell. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

3 Stocks Under $50 That Concern Us

April 29, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

1 Profitable Stock to Target This Week and 2 to Steer Clear Of

April 24, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Topics Artificial Intelligence

Reflecting On Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks’ Q4 Earnings: Merit Medical Systems (NASDAQ:MMSI)

April 17, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Merit Medical Systems...

Via StockStory

Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

April 15, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Artivion (NYSE:AORT) and...

Via StockStory

1 Small-Cap Stock on Our Watchlist and 2 to Avoid

March 31, 2025

Via StockStory

Artivion (AORT): Buy, Sell, or Hold Post Q4 Earnings?

March 28, 2025

Over the last six months, Artivion shares have sunk to $24.36, producing a disappointing 8.5% loss - worse than the S&P 500’s 1.4% drop. This was partly due to its softer quarterly results and might...

Via StockStory

Topics Stocks Supply Chain

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

March 25, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including ICU Medical (NASDAQ:ICUI) and its peers.

Via StockStory

ICU Medical (ICUI) Q4 Earnings Report Preview: What To Look For

February 26, 2025

Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results tomorrow after market close. Here’s what you need to know.

Via StockStory

Artivion (AORT) Stock Trades Down, Here Is Why

February 25, 2025

Shares of medical device company Artivion (NYSE:AORT) fell 11.2% in the morning session after the company reported weak fourth-quarter 2024 results, as both revenue and EPS missed Wall Street's...

Via StockStory

Artivion (NYSE:AORT) Misses Q4 Sales Targets

February 24, 2025

Medical device company Artivion (NYSE:AORT) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 3.9% year on year to $97.31 million. The company’s full-year revenue guidance of $427.5...

Via StockStory

Artivion (AORT) Q4 Earnings: What To Expect

February 23, 2025

Medical device company Artivion (NYSE:AORT) will be reporting results tomorrow after the bell. Here’s what you need to know.

Via StockStory

Earnings Scheduled For February 24, 2025 ↗

February 24, 2025

Via Benzinga

Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack

February 14, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers.

Via StockStory

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.